IP Library Granted Patent US 10,351,795
Granted Patent B2
US 10,351,795 · App. 15/126,098 · Granted Jul 16, 2019

Polypeptides having phospholipase C activity and polynucleotides encoding same

Inventors: Dorotea Raventos Segura (Rungsted, DK); Robert Piotr Olinski (Vaerlose, DK); Kim Borch (Birkerod, DK); Allan Noergaard (Lyngby, DK); Jesper Brask (Vaerlose, DK); Rune Falkenberg Haller (Roskilde, DK); Marianne Linde Damstrup (Gentofte, DK)
Assignee: Novozymes A/S
C11B3/003C12N9/16C12N9/20C12P7/6445C12Y301/04003C12Y301/04011
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,351,795
App. No.
15/126,098
Granted
Jul 16, 2019
Kind
B2
Abstract

The present invention relates to a method of reducing the phospholipid content in an oil or fat composition and polypeptides having PI-specific phospholipase C activity as well as polypeptides having PC, PE-specific phospholipase C activity and combinations thereof capable of catalyzing this reduction. The invention also relates to polynucleotides encoding the polypeptides, nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.

Claims (35)

1. A composition comprising

(a) a phosphatidylinositol phospholipase C having at least 91% sequence identity to amino acid residues 26-322 of SEQ ID NO: 2 or amino acid residues 1-298 of SEQ ID NO: 3; and

(b) a phosphatidylcholine (“PC”) and phosphatidylethanolamine (“PE”)-specific phospholipase C polypeptide having at least 90% sequence identity to amino acid residues 25-283 of SEQ ID NO: 22 or amino acid residues 39-283 of SEQ ID NO: 22.

2. The composition of claim 1 , wherein

(a) the phosphatidylinositol phospholipase C has at least 95% sequence identity to amino acid residues 26-322 of SEQ ID NO: 2 or amino acid residues 1-298 of SEQ ID NO: 3; and

(b) the phosphatidylcholine (“PC”) and phosphatidylethanolamine (“PE”)-specific phospholipase C polypeptide has at least 95% sequence identity to amino acid residues 39-283 of SEQ ID NO: 22.

3. The composition of claim 1 , wherein

(a) the phosphatidylinositol phospholipase C has at least 98% sequence identity to amino acid residues 26-322 of SEQ ID NO: 2 or amino acid residues 1-298 of SEQ ID NO: 3; and

(b) the phosphatidylcholine (“PC”) and phosphatidylethanolamine (“PE”)-specific phospholipase C polypeptide has at least 98% sequence identity to amino acid residues 39-283 of SEQ ID NO: 22.

4. The composition of claim 1 , wherein

(a) the phosphatidylinositol phospholipase C is amino acid residues 26-322 of SEQ ID NO: 2 or amino acid residues 1-298 of SEQ ID NO: 3 or a fragment thereof which has phosphatidylinositol phospholipase C activity; and

(b) the phosphatidylcholine (“PC”) and phosphatidylethanolamine (“PE”)-specific phospholipase C polypeptide is amino acid residues 39-283 of SEQ ID NO: 22 or a fragment thereof which has phosphatidylcholine (“PC”) and phosphatidylethanolamine (“PE”)-specific phospholipase C activity.

5. The composition of claim 1 , wherein

(a) the phosphatidylinositol phospholipase C is amino acid residues 26-322 of SEQ ID NO: 2 or amino acid residues 1-298 of SEQ ID NO: 3; and

(b) the phosphatidylcholine (“PC”) and phosphatidylethanolamine (“PE”)-specific phospholipase C polypeptide is amino acid residues 39-283 of SEQ ID NO: 22.

6. A method for reducing the content of phospholipids in an oil composition, the method comprising

(a) contacting an oil composition containing a quantity of phospholipids with a composition of claim 1 ; and

(b) separating the phosphate ester from the oil composition.

7. A method for reducing the content of phospholipids in an oil composition, the method comprising

(a) contacting an oil composition containing a quantity of phospholipids with a composition of claim 2 ; and

(b) separating the phosphate ester from the oil composition.

8. A method for reducing the content of phospholipids in an oil composition, the method comprising

(a) contacting an oil composition containing a quantity of phospholipids with a composition of claim 3 ; and

(b) separating the phosphate ester from the oil composition.

9. A method for reducing the content of phospholipids in an oil composition, the method comprising

(a) contacting an oil composition containing a quantity of phospholipids with a composition of claim 4 ; and

(b) separating the phosphate ester from the oil composition.

10. A method for reducing the content of phospholipids in an oil composition, the method comprising

(a) contacting an oil composition containing a quantity of phospholipids with a composition of claim 5 ; and

(b) separating the phosphate ester from the oil composition.

11. The method of claim 6 , wherein the oil composition is an edible oil.

12. The method of claim 6 , wherein the oil composition is selected from crude oil, water degummed oil, caustic refined oil and acid degummed oil.

13. The method of claim 6 , wherein the oil is contacted with 0.5-200 mg enzyme protein (EP)/Kg oil of the phosphatidylinositol phospholipase C and with 0.5-200 mg enzyme protein (EP)/Kg oil of the PC and PE-specific phospholipase C.

14. The method of claim 6 , wherein the oil is contacted with 1-25 mg enzyme protein (EP)/Kg oil of the phosphatidylinositol phospholipase C and with 1-25 mg enzyme protein (EP)/Kg oil of the PC and PE-specific phospholipase C.

15. The method of claim 6 , wherein the oil is contacted with 2-15 mg enzyme protein (EP)/Kg oil of the phosphatidylinositol phospholipase C and with 2-15 mg enzyme protein (EP)/Kg oil of the PC and PE-specific phospholipase C.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 8, 2017
From: SEGURA, DOROTEA RAVENTOS; OLINSKI, ROBERT PIOTR; BORCH, KIM; NOERGAARD, ALLAN; BRASK, JESPER; HALLER, RUNE FALKENBERG; DAMSTRUP, MARIANNE LINDE
To: NOVOZYMES A/S
Reel/Frame 042643/0926 →
Priority Claims (1)
EP 14160698 · Mar 19, 2014 · regional
Continuity (1)
Related Publication 20170096619A1 · Apr 6, 2017
Cited By (2)
US 12,410,414 US 12,460,151